Clinical Trials · NCT07392151
Reversal to Normoglycemia by Treating Prediabetes
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Michael Mæng
- Enrollment
- 158
- Start date
- Feb 2026
- Locations
- 1 site, Denmark
- Primary endpoint
- Presence of a composite of retinopathy, nephropathy, neuropathy, and MASLD